COMMUNIQUÉS West-GlobeNewswire

Collegium to Participate in Upcoming Investor Conference

25/09/2019 - 14:00

STOUGHTON, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that [...]

Athersys to Present at 2019 Cell & Gene Meeting on the Mesa

25/09/2019 - 14:00

Conference being held October 2nd- 4th, 2019 in Carlsbad; live video webcast available CLEVELAND, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and [...]

electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™

25/09/2019 - 14:00

Additional information requested by FDA; Premium 2 trial progressing as planned BASKING RIDGE, N.J., Sept. 25, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR, or the “Company”), a commercial-stage [...]

GBT Announces Participation at the 2019 Cantor Global Healthcare Conference

25/09/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2019 Cantor Global Healthcare Conference in New York City [...]

TYME Launches Pivotal Stage of TYME-88-PANC Trial to Evaluate SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer

25/09/2019 - 14:00

Oral SM-88 represents a new approach designed to selectively disrupt protein synthesis in cancers with demonstrated responses in 15 different cancer types across four separate studies Data presented at ESMO GI 2019 from [...]

Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent

25/09/2019 - 14:00

Leveraging Growing Patent Estate Creates Value and Strengthens Core Competency HOUSTON, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary [...]

AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

25/09/2019 - 14:00

WALTHAM, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Cantor Fitzgerald Global Healthcare Conference in New York on Thursday, October 3, 2019. Ted Myles, [...]

Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study

25/09/2019 - 14:00

Both norovirus vaccines induced substantial immune responses with no indication of immunological interference when administered concurrently Phase 2-ready oral norovirus vaccine targets potential $3B+ market opportunity [...]

resTORbio to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

25/09/2019 - 14:00

BOSTON, Sept. 25, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related [...]

SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019

25/09/2019 - 13:30

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Dennis E. Hruby, the [...]

VitalHub Corp. Announces Early Redemption Of $2,219,000 Outstanding Debentures & New Debt Financing

25/09/2019 - 13:30

TORONTO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV: VHI) (the “ Company ” or “ VitalHub ”) is pleased to announce that it has redeemed in full the $2,219,000 aggregate principal amount of outstanding [...]

Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference

25/09/2019 - 13:30

SAN DIEGO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Dance Biopharm Announces Rebranding to Aerami Therapeutics Reflecting a Broadened Strategic Focus on Inhaled Therapies for Chronic Diseases

25/09/2019 - 13:30

Aerami is exploring inhaled therapies beyond human insulin in multiple chronic conditions Launched three new pipeline programs aimed at treatment of type 2 diabetes, hypoparathyroidism and human growth hormone [...]

AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients

25/09/2019 - 13:30

Excellent safety results seen in CF patients, with CFA in line with previous studies and no need for a protease Management to discuss the results on a call scheduled for today, September 25, 2019 at 8:30 a.m. Eastern [...]

T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands

25/09/2019 - 13:30

LEXINGTON, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it [...]

Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals

25/09/2019 - 13:30

Grants Support Community Engagement for Patient Advocacy Organizations Focused on Cardiovascular or Neuromuscular Diseases Deadline for Applications is November 15 th , 2019 SOUTH SAN FRANCISCO, Calif., Sept. 25, 2019 ( [...]

Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure

25/09/2019 - 13:30

Data indicate ITI-214 at a dose of 30 mg is well tolerated with a favorable safety profile Study ‘104 now proceeding to a third cohort at a dose of 90 mg NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular [...]

RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019

25/09/2019 - 13:05

RTI announces interim clinical outcomes on 150 patients at 6-month follow-up in the EVoluSIon study for the SImmetry® Sacroiliac Joint Fusion System showing statistically significant reductions in pain of 56% and opioid [...]

Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer

25/09/2019 - 13:00

Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) TORONTO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative [...]